Relevant bibliographies by topics / In-Vitro Testing of Quick Dissolving Tablets

Contents

  1. Journal articles
  2. Book chapters

Academic literature on the topic 'In-Vitro Testing of Quick Dissolving Tablets'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'In-Vitro Testing of Quick Dissolving Tablets.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "In-Vitro Testing of Quick Dissolving Tablets"

1

Aarti, Nimse* Dr. Sachin Kale Dr. K. R. Biyani. "Formulation And In-Vitro Testing of Quick Dissolving Tablets of Nsaids Drug Along with Musa Paradisiaca Powder." International Journal of Pharmaceutical Sciences 3, no. 5 (2025): 3468–73. https://doi.org/10.5281/zenodo.15475438.

Full text
Abstract:
Lornoxicam is a non-steroidal anti-inflammatory medication commonly used as an anti-inflammatory, analgesic and antipyretic agent.  Conventional solid dosage forms are frequently linked to a faster disintegration time, but oral bioavailability is poor, with only 50% of the dose reaching systemic circulation due to substantial first pass metabolism.  Because the banana powder in the fast-dissolving tablets dissolves quickly, the medication is released right away. Two to four hours is the elimination half-life.  For patients at high risk of developing NSAID-induced stomach and duo
APA, Harvard, Vancouver, ISO, and other styles
2

Kaur, Manpreet, Amit Mittal, Monica Gulati, Deepika Sharma, and Rajesh Kumar. "Formulation and in vitro Evaluation of Fast Dissolving Tablets of Febuxostat Using Co-Processed Excipients." Recent Patents on Drug Delivery & Formulation 14, no. 1 (2020): 48–62. http://dx.doi.org/10.2174/1872211314666191224121044.

Full text
Abstract:
Background: Febuxostat is a novel, orally-administered, powerful, non-purine, xanthine oxidase inhibitor used for treating gout and ceaseless tophaceous gout. The drug exhibits low bioavailability (about 49%) which is ascribed to its dissolution rate-limited absorption. Objective: The current work is aimed to provide a novel strategy to improve the dissolution profile and thus, the bioavailability of Febuxostat. Methods: Formulation of Fast Dissolving Tablets (FDT) is anticipated to provide immediate release of the drug, which in turn, will improve its dissolution profile to provide the initia
APA, Harvard, Vancouver, ISO, and other styles
3

Ali, Hany S. M., Sameh A. Ahmed, Abdulmalik A. Alqurshi, Ali M. Alalawi, Ahmed M. Shehata, and Yaser M. Alahmadi. "Tadalafil-Loaded Self-Nanoemulsifying Chewable Tablets for Improved Bioavailability: Design, In Vitro, and In Vivo Testing." Pharmaceutics 14, no. 9 (2022): 1927. http://dx.doi.org/10.3390/pharmaceutics14091927.

Full text
Abstract:
This research aimed to develop innovative self-nanoemulsifying chewable tablets (SNECT) to increase oral bioavailability of tadalafil (TDL), a nearly insoluble phosphodiesterase-5 inhibitor. Cinnamon essential oil, PEG 40 hydrogenated castor oil (Cremophor® RH 40), and polyethylene glycol 400 served as the oil, surfactant, and cosurfactant in the nanoemulsifying system, respectively. Primary liquid self-nanoemulsifying delivery systems (L-SNEDDS) were designed using phase diagrams and tested for dispersibility, droplet size, self-emulsifying capability, and thermodynamic stability. Adsorption
APA, Harvard, Vancouver, ISO, and other styles
4

Prajapati, Vinitbhai*1 Himanshu Sharma2 Sagar Patra3 Sahilahmad Makarani3 Mahendrakumar Dubey1. "A Contemporary Approach to The Medicate Conveyane Through Orodispersible Tablets." International Journal of Scientific Research and Technology 1, no. 12 (2024): 29–40. https://doi.org/10.5281/zenodo.14285188.

Full text
Abstract:
The development of dosage forms that are easy to manufacture and administer, as well as rapid release and increased bioavailability, have led to new drug delivery systems. To achieve the desired result, drugs must be delivered to the site of action at a speed and concentration that maximizes therapeutic benefits and minimizes side effects. The most popular and efficient way of drug administration is oral. Recently, many medicinal products have been released in the market. The use of lyophilizers and oral tablets or films have expanded treatment options. Both children and adults can benefit fro
APA, Harvard, Vancouver, ISO, and other styles
5

Panjwani, Alysha, Yong Zhu, Keiichiro Kushiro, Sam Lai, and Kathleen Vincent. "Sheep Postcoital Testing to Evaluate Antibody-Based, Nonhormonal Contraceptive Tablet [ID 1459]." Obstetrics & Gynecology 145, no. 6S (2025): 64S. https://doi.org/10.1097/aog.0000000000005918.020.

Full text
Abstract:
INTRODUCTION: Efficacy of on-demand nonhormonal contraception that targets and disables progressively motile sperm (PMS) can be studied through surrogate postcoital testing (PCT) in sheep models, due to similarities to human reproductive tract size and anatomy. We utilized PCT to assess the contraceptive potential of anti-sperm antibody in tablet form in vivo in sheep. METHODS: Pooled semen from five prescreened human male donors was collected and evaluated for adequate motility prior to use. Ewes (n=6) were given a quick-dissolving tablet delivering active anti-sperm antibody, a placebo table
APA, Harvard, Vancouver, ISO, and other styles
6

Patil, Shailesh B., and Jitendra D. More. "Expansion and Valuation of Naproxen Sodium Fast Dissolving Tablet." Journal of Pharmaceutical Research 23, no. 3 (2024): 178–88. http://dx.doi.org/10.18579/jopcr/v23.3.98.

Full text
Abstract:
The evaluation of Naproxen Sodium Fast Dissolving Tablets emphasizes the critical role of careful formulation design and thorough testing in pharmaceutical development. Among the formulations, F7 demonstrated outstanding properties, including excellent flow characteristics and optimal tablet hardness. Stability testing over a four-week period showed consistent performance, though minor variations in tablet attributes were observed. Continuous monitoring is advised to ensure sustained efficacy. The in-vitro release profile revealed rapid disintegration and dissolution, crucial for prompt drug r
APA, Harvard, Vancouver, ISO, and other styles
7

Bindal, Rishabh, and Arpna Indurkhya. "Formulation and Evaluation of Ketorolac Tromethamine Mouth Dissolving Tablets." Journal of Drug Delivery and Therapeutics 11, no. 1 (2021): 60–64. http://dx.doi.org/10.22270/jddt.v11i1.4502.

Full text
Abstract:
Due to more versatility and comfort, mouth dissolving tablets are the most advanced type of oral solid dosage forms. Compared to conventional tablets, it increases the effectiveness of APIs by dissolving within a minute in the oral cavity after contact with less saliva, without chewing and without the need for water for administration. Mouth Dissolving Tablets of Ketorolac tromethamine were prepared by direct compression method using various superdisintegrants like crospovidone, Croscarmellose sodium, and Sodium starch glycolate in different concentrations. Prepared tablets were evaluated for
APA, Harvard, Vancouver, ISO, and other styles
8

Gurram, Syam Sundar, Nagaveni P, and Sreevalli Arigela. "Formulation and evaluation of nifedipine fast dissolving tablets." Future Journal of Pharmaceuticals and Health Sciences 4, no. 2 (2024): 32–38. http://dx.doi.org/10.26452/fjphs.v4i2.599.

Full text
Abstract:
The current study aims to formulate and evaluate the fast-dissolving tablet. The optimal concentration of Guar gum super disintegrate was found to be 20 mg, with a disintegration time of 27 seconds. This study assessed the disintegration time of tablets containing natural super disintegrant for the Disintegration test at various weight concentrations (6,8,10,12,14,16,18, and 20 mg). As a result, the Nifedipine fast dissolving tablets with Guar gum super disintegrant provide a quick therapeutic effect, a high dissolve rate, and a shorter disintegration time. In this study, the use of a natural
APA, Harvard, Vancouver, ISO, and other styles
9

Gurram, Syam Sundar. "Formulation and evaluation of nifedipine fast dissolving tablets." Formulation and evaluation of nifedipine fast dissolving tablets 4, no. 2 (2025): 32–38. https://doi.org/10.5281/zenodo.14651206.

Full text
Abstract:
The current study aims to formulate and evaluate the fast-dissolving tablet. The optimal concentration of Guar gum super disintegrate was found to be 20 mg, with a disintegration time of 27 seconds. This study assessed the disintegration time of tablets containing natural super disintegrant for the Disintegration test at various weight concentrations (6,8,10,12,14,16,18, and 20 mg). As a result, the Nifedipine fast dissolving tablets with Guar gum super disintegrant provide a quick therapeutic effect, a high dissolve rate, and a shorter disintegration time. In this study, the use of a natural
APA, Harvard, Vancouver, ISO, and other styles
10

Sukhavasi, Sudheshnababu, and V. Sai Kishore. "Formulation and evaluation of fast dissolving tablets of amlodipine besylate by using Fenugreek seed mucilage and Ocimum basilicum gum." International Current Pharmaceutical Journal 1, no. 9 (2012): 243–49. http://dx.doi.org/10.3329/icpj.v1i9.11614.

Full text
Abstract:
Fast dissolving/disintegrating tablets have received ever-increasing demand during the last decade, and the field has became a rapidly growing area in the pharmaceutical area. Particularly the fast dissolving drug delivery systems formulated with natural polymers have more demand because natural materials like gums and mucilages have been extensively used in the field of drug delivery for their easy availability, ease administration, non toxicity, non irritant nature etc. The main aim of the present study was to formulate the fast dissolving tablets of amlodipine besylate tablets using Fenugre
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "In-Vitro Testing of Quick Dissolving Tablets"

1

Mohammed, Jahasultana, and Buchi N. Nalluri. "Development and Validation of RP-HPLC-PDA Method for the Estimation of Fluoxetine Hydrochloride in Bulk, Mouth Dissolving Films and in Dissolution Samples." In Current Trends in Drug Discovery, Development and Delivery (CTD4-2022). Royal Society of Chemistry, 2023. http://dx.doi.org/10.1039/9781837671090-00283.

Full text
Abstract:
Selective serotonin reuptake inhibitor, fluoxetine hydrochloride (FLX) is a drug of choice for treating depression, obsessive-compulsive disorder (OCD), bulimia nervosa, etc. Even though FLX dosage forms such as tablets, capsules, oral solutions, and syrups are already available commercially, there is a considerable need for developing modified or immediate-release formulations with a quick onset of action and high bioavailability. The goal of this research is to provide a quick, practical, and cost-effective RP-HPLC-PDA approach for determining Fluoxetine hydrochloride (FLX) in bulk, mouth di
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'In-Vitro Testing of Quick Dissolving Tablets' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography